Certified by Founder Lodge
Forty51 Ventures
Switzerland - Basel
INVESTOR
1 Disclosed Funding Rounds $80,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Biotech fund
| Company | Date | Round | Raised |
|---|---|---|---|
 Mosanna Therapeutics |
June, 10 ,2025 | Series A | $80,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
FOVC | $2,000,000 | (Jan 16, 2026)
CYB3R OPERATIONS | $5,400,000 | (Jan 16, 2026)
Project Eleven | $20,000,000 | (Jan 16, 2026)
depthfirst | $40,000,000 | (Jan 16, 2026)
Quadric | $30,000,000 | (Jan 16, 2026)
